Skip to content
ChinaCSR.com logo

Corporate Social Responsibility & Sustainability in China

Corporate Social Responsibility in China

China Recalls Problematic Eye Drops

September 25, 2009
-
Health

China's State Food and Drug Administration has issued a circular that asks for the recall of substandard batches of chloramphenicol eye drops made by Tianjin Wanjia Pharmaceutical Company.

It is learned from the Tianjin Municipal Food and Drug Administration that, during an inspection in 2009, 16 batches of chloramphenicol eye drops made by Tianjin Wanjia were found to be substandard due to particle content. So far, TMFDA has ordered the company to recall all the eye drops involved.

It is understood that eye drops containing chloramphenicol are mainly used to treat conjunctivitis, trachoma, keratitis, and blepharitis ciliaris. Because of its relatively low price, it is a fast-selling medicine.

Tags: blepharitis ciliaris, chloramphenicol, conjunctivitis, eye drops, keratitis, medicine, pharmaceutical, SFDA, Tianjin Wanjia Pharmaceutical Company, trachoma

Readers also read this:

Caterpillar China R&D Center Gets LEED Gold Certification

November 16, 2010

China Province To Eliminate Disposable Amenities From Hotels

November 5, 2010

Unilever China Wins China Green Gold Award

November 4, 2010

ZTE Organizes CSR Conference In Sanya

November 3, 2010

ADB And Tongji University Establish Urban Knowledge Hub

November 2, 2010

Yingli Green Energy Expands Production Capacity

November 1, 2010
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文
Menu
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文

Copyright 2025 © ChinaCSR.com. All Rights Reserved. A service of Asia Media Network. If you would like to syndicate these articles and posts, please utilize the RSS feed for this online publication, which provides a brief summary of each post with a link back to the original article. Posting of any other part of the articles or posts on this website for commercial purposes created by ChinaCSR.com, in whole or in part, is expressly prohibited without express written permission from ChinaCSR.com. Individual news stories curated from other sources are copyright their respective sources.

Asia Media Network